Literature DB >> 20692541

Pulmonary involvement in Sjögren syndrome.

Maria Kokosi1, Ellen C Riemer, Kristin B Highland.   

Abstract

Sjögren syndrome is a slowly progressing autoimmune disease. Pulmonary manifestations are frequent in primary Sjögren syndrome but often not clinically significant; the most common are xerotrachea, interstitial lung diseases, and small airway obstruction. Pulmonary manifestations in Sjögren syndrome have a slow progression and favorable prognosis, with the exception of primary pulmonary lymphoma and pulmonary hypertension.

Entities:  

Mesh:

Year:  2010        PMID: 20692541     DOI: 10.1016/j.ccm.2010.05.007

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  17 in total

1.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The lung may play a role in the pathogenesis of rheumatoid arthritis.

Authors:  M Kristen Demoruelle; Joshua J Solomon; Aryeh Fischer; Kevin D Deane
Journal:  Int J Clin Rheumtol       Date:  2014

3.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal).

Authors:  Virginia Fernandes Moça Trevisani; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Marilena Leal Mesquita Silvestre Fernandes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D'Agostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Aline Pereira da Rocha; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-06-01

4.  Severe Pulmonary Hypertension in Primary Sjögren's Syndrome.

Authors:  Ji-An Hwang; Tae-Hyun Yang; Ji-Young Lee; Dong-Wan Koo; In Suk Choi; Sun-Young Cho; Min-Sung Kim
Journal:  Korean Circ J       Date:  2013-07-31       Impact factor: 3.243

Review 5.  Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.

Authors:  Rekha Vij; Mary E Strek
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

6.  Comparison of short-term outcomes for connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis after lung transplantation.

Authors:  Ji Eun Park; Song Yee Kim; Joo Han Song; Young Sam Kim; Joon Chang; Jin Gu Lee; Hyo Chae Paik; Moo Suk Park
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

7.  Rare case of Primary Pulmonary Extranodal Non-Hodgkin's Lymphoma in a Patient with Sjogren's Syndrome: Role of FDG-PET/CT in the Initial Staging and Evaluating Response to Treatment.

Authors:  Gonca Bural; Judith Joyce; James Ohr
Journal:  Mol Imaging Radionucl Ther       Date:  2012-12-20

8.  Association between Sjogren's syndrome and respiratory failure: put airway, interstitia, and vessels close together: a national cohort study.

Authors:  Jun-Jun Yeh; Hsuan-Ju Chen; Tsai-Chung Li; Yi-Sin Wong; Hsien-Chin Tang; Ting-Chun Yeh; Chia-Hung Kao
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

9.  Long-term clinical course and outcome in patients with primary Sjögren syndrome-associated interstitial lung disease.

Authors:  Yun Jae Kim; Jooae Choe; Ho Jeong Kim; Jin Woo Song
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

10.  Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.

Authors:  Yasunori Enomoto; Tamiko Takemura; Eri Hagiwara; Tae Iwasawa; Yuh Fukuda; Noriyo Yanagawa; Fumikazu Sakai; Tomohisa Baba; Shouhei Nagaoka; Takashi Ogura
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.